Catherine M. Engelbert insider trades

Open-market stock purchases and sales by Catherine M. Engelbert, Director at Royalty Pharma plc, from SEC Form 4 filings since Dec 31, 2019.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +17%.

Recent trades

DateStockTradeValue
Jun 5, 2026RPRX Royalty Pharma plcBought (not open market)—
Dec 31, 2025MCD McDonalds CorpBought (not open market)$205K

Companies traded

  • RPRX Royalty Pharma plc: other filings, last Jun 5, 2026
  • MCD McDonalds Corp: 3 buys, last Dec 31, 2025

Get free alerts when Catherine M. Engelbert files a new trade →